Pyrimethamine Leucovorin (ImprimisRx PA, Inc. d/b/a ImprimisRx)
Welcome to the PulseAid listing for the Pyrimethamine Leucovorin drug offered from ImprimisRx PA, Inc. d/b/a ImprimisRx. This Dihydrofolate Reductase Inhibitor Antimalarial [EPC],Dihydrofolate Reductase Inhibitors [MoA],Folate Analog [EPC],Folic Acid [Chemical/Ingredient],Analogs/Derivatives [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | ImprimisRx PA, Inc. d/b/a ImprimisRx |
| NON-PROPRIETARY NAME: | Pyrimethamine Leucovorin |
| SUBSTANCE NAME: | PYRIMETHAMINE; LEUCOVORIN CALCIUM |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Dihydrofolate Reductase Inhibitor Antimalarial [EPC],Dihydrofolate Reductase Inhibitors [MoA],Folate Analog [EPC],Folic Acid [Chemical/Ingredient],Analogs/Derivatives [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | UNAPPROVED DRUG OTHER |
| START MARKETING DATE: | 2015-11-27 |
| END MARKETING DATE: | 0000-00-00 |
Pyrimethamine Leucovorin HUMAN PRESCRIPTION DRUG Details:
| Item Description | Pyrimethamine Leucovorin from ImprimisRx PA, Inc. d/b/a ImprimisRx |
| LABELER NAME: | ImprimisRx PA, Inc. d/b/a ImprimisRx |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 25; 5(mg/1; mg/1) |
| START MARKETING DATE: | 2015-11-27 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 70271-426_926ec8fb-4382-4740-9302-c0d457915248 |
| PRODUCT NDC: | 70271-426 |
| APPLICATION NUMBER: | |
Other PYRIMETHAMINE; LEUCOVORIN CALCIUM Pharmaceutical Manufacturers / Labelers:
